A Real-World Prospective Study of the Safety and Effectiveness of the Loop Open Source Automated Insulin Delivery System-Reference-Cited by-同舟云学术

A Real-World Prospective Study of the Safety and Effectiveness of the Loop Open Source Automated Insulin Delivery System

Published:2021-05-01 Issue:5 Volume:23 Page:367-375
ISSN:1520-9156
Container-title:Diabetes Technology & Therapeutics
language:en
Short-container-title:Diabetes Technology & Therapeutics

Author:

Lum John W.¹,Bailey Ryan J.¹,Barnes-Lomen Victoria¹,Naranjo Diana²,Hood Korey K.²,Lal Rayhan A.²,Arbiter Brandon³,Brown Adam S.³,DeSalvo Daniel J.⁴,Pettus Jeremy⁵,Calhoun Peter¹,Beck Roy W.¹

Affiliation:

1. Jaeb Center for Health Research, Tampa, Florida, USA.

2. Department of Pediatrics and Medicine, Stanford University School of Medicine, Stanford, California, USA.

3. Tidepool, Palo Alto, California, USA.

4. Section of Pediatric Diabetes and Endocrinology, Baylor College of Medicine, Houston, Texas, USA.

5. Division of Endocrinology, University of California, San Diego, San Diego, California, USA.

Publisher

Mary Ann Liebert Inc

Subject

Medical Laboratory Technology,Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.liebertpub.com/doi/pdf/10.1089/dia.2020.0535

Reference7 articles.

1. Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring

2. Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range

3. Safety of a Hybrid Closed-Loop Insulin Delivery System in Patients With Type 1 Diabetes

4. Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes

5. Safety Evaluation of the MiniMed 670G System in Children 7–13 Years of Age with Type 1 Diabetes

Cited by 92 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Refining Insulin on Board with netIOB for Automated Insulin Delivery;Journal of Diabetes Science and Technology;2024-08-14

2. Open-Source-AID-Systeme (AID: automatische Insulindosierung) bei Kindern und Jugendlichen;Die Diabetologie;2024-08-12

3. Real-World Evidence of Omnipod^® 5 Automated Insulin Delivery System Use in 69,902 People with Type 1 Diabetes;Diabetes Technology & Therapeutics;2024-08-01

4. Use of the Community-Derived Open-Source Automated Insulin Delivery Loop System in Type 2 Diabetes;Diabetes Technology & Therapeutics;2024-07-01

5. A single‐site feasibility randomised controlled trial comparing ‘my hypo compass’ short pyscho‐educational intervention with standard care alone in individuals with type 1 diabetes and impaired awareness of hypoglycaemia;Diabetic Medicine;2024-06-26